1-20 of 52
Ping Yue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3725: B-Raf inhibition-induced paradoxical activation of MEK/ERK signaling enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells

You-Take Oh, Jiusheng Deng, Ping Yue, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3725.
https://doi.org/10.1158/1538-7445.AM2016-3725
Published: 15 July 2016
View article titled, Abstract 3725: B-Raf inhibition-induced paradoxical activation of MEK/ERK signaling enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells
Journal Articles

Abstract 2105: c-Met hyperactivation is an universal resistance mechanism to both first and third generation EGFR inhibitors

Puyu Shi, You-Take Oh, Guojing Zhang, Weilong Yao, Ping Yue, Rajani Kanteti, Jacob Riehm, Ravi Salgia, Taofeek Owonikoko, Suresh S. Ramalingam, Mingwei Chen, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2105.
https://doi.org/10.1158/1538-7445.AM2016-2105
Published: 15 July 2016
View article titled, Abstract 2105: c-Met hyperactivation is an universal resistance mechanism to both first and third generation EGFR inhibitors
Journal Articles

Abstract LB-101: The expression of death receptor 4 is positively regulated by MEK/ERK signaling and suppressed upon MEK inhibition

You-Take Oh, Weilong Yao, Jiusheng Deng, Ping Yue, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-101.
https://doi.org/10.1158/1538-7445.AM2016-LB-101
Published: 15 July 2016
View article titled, Abstract LB-101: The expression of death receptor 4 is positively regulated by MEK/ERK signaling and suppressed upon MEK inhibition
Journal Articles

Abstract 2288: Pharmacological inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs cancer cell response to DR5 activation-induced apoptosis

You-Take Oh, Ping Yue, Taofeek K. Owonikoko, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2288.
https://doi.org/10.1158/1538-7445.AM2014-2288
Published: 01 October 2014
View article titled, Abstract 2288: Pharmacological inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs cancer cell response to DR5 activation-induced apoptosis
Journal Articles

Abstract 349: mTOR complex 2 (mTORC2) positively regulates Mcl-1 stability by suppressing GSK3-dependent and FBXW7-mediated proteasomal degradation of Mcl-1

Junghui Koo, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 349.
https://doi.org/10.1158/1538-7445.AM2014-349
Published: 01 October 2014
View article titled, Abstract 349: mTOR complex 2 (mTORC2) positively regulates Mcl-1 stability by suppressing GSK3-dependent and FBXW7-mediated proteasomal degradation of Mcl-1
Journal Articles

Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth

Junghui Koo, Ping Yue, Anthony A. Gal, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2014) 74 (9): 2555–2568.
https://doi.org/10.1158/0008-5472.CAN-13-2946
Published: 30 April 2014
View article titled, Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth
Open the PDF for Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth in another window
Includes: Supplementary data
Journal Articles

Abstract LB-41: Rictor undergoes GSK3-dependent, FBXW7-mediated ubiquitination and proteasomal degradation.

Junghui Koo, Xiayun Wu, Ping Yue, Zixu Mao, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-41.
https://doi.org/10.1158/1538-7445.AM2013-LB-41
Published: 15 April 2013
View article titled, Abstract LB-41: Rictor undergoes GSK3-dependent, FBXW7-mediated ubiquitination and proteasomal degradation.
Journal Articles

Abstract 3282: Poly (ADP) ribose polymerase (PARP) enzyme inhibitor, CEP8983, potentiates bendamustine activity in small cell lung cancer (SCLC).

Taofeek Kunle Owonikoko, Guojing Zhang, Ping Yue, Suresh Ramalingam, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3282.
https://doi.org/10.1158/1538-7445.AM2013-3282
Published: 15 April 2013
View article titled, Abstract 3282: Poly (ADP) ribose polymerase (PARP) enzyme inhibitor, CEP8983, potentiates bendamustine activity in small cell lung cancer (SCLC).
Journal Articles

Abstract 2625: Knockdown of death receptor 5 promotes cancer cell invasion through activation of the ERK and JNK signaling pathways.

You-Take Oh, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2625.
https://doi.org/10.1158/1538-7445.AM2013-2625
Published: 15 April 2013
View article titled, Abstract 2625: Knockdown of death receptor 5 promotes cancer cell invasion through activation of the ERK and JNK signaling pathways.
Journal Articles

mTOR Complex 2 Is Involved in Regulation of Cbl-Dependent c-FLIP Degradation and Sensitivity of TRAIL-Induced Apoptosis

Liqun Zhao, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2013) 73 (6): 1946–1957.
https://doi.org/10.1158/0008-5472.CAN-12-3710
Published: 14 March 2013
View article titled, mTOR Complex 2 Is Involved in Regulation of Cbl-Dependent c-FLIP Degradation and Sensitivity of TRAIL-Induced Apoptosis
Open the PDF for mTOR Complex 2 Is Involved in Regulation of Cbl-Dependent c-FLIP Degradation and Sensitivity of TRAIL-Induced Apoptosis in another window
Includes: Supplementary data
Journal Articles

Abstract 261: The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition

Bo Li, Hui Rentsch, Ping Yue, Mingwei Chen, Fadlo R. Khuri, Shiyong Sun
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 261.
https://doi.org/10.1158/1538-7445.AM2012-261
Published: 15 April 2012
View article titled, Abstract 261: The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition
Journal Articles

Abstract 4885: mTOR complex 2 is involved in regulation of c-FLIP stability and sensitization of TRAIL-induced apoptosis

Liqun Zhao, Ping Yue, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4885.
https://doi.org/10.1158/1538-7445.AM2012-4885
Published: 15 April 2012
View article titled, Abstract 4885: mTOR complex 2 is involved in regulation of c-FLIP stability and sensitization of TRAIL-induced apoptosis
Journal Articles

Abstract 2803: GSK3 plays a crucial role in determining cell response to mTOR inhibitors

Junghui Koo, Ping Yue, Hui Tao, Suresh S. Ramalingam, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2803.
https://doi.org/10.1158/1538-7445.AM2012-2803
Published: 15 April 2012
View article titled, Abstract 2803: GSK3 plays a crucial role in determining cell response to mTOR inhibitors
Journal Articles

Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3

Shuzhen Chen, Wei Cao, Ping Yue, Chunhai Hao, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2011) 71 (19): 6270–6281.
https://doi.org/10.1158/0008-5472.CAN-11-0838
Published: 29 September 2011
View article titled, Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3
Open the PDF for Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3 in another window
Includes: Supplementary data
Journal Articles

Retinoic Acid Enhances TRAIL-Induced Apoptosis in Cancer Cells by Upregulating TRAIL Receptor 1 Expression

Latha Dhandapani, Ping Yue, Suresh S. Ramalingam, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2011) 71 (15): 5245–5254.
https://doi.org/10.1158/0008-5472.CAN-10-4180
Published: 28 July 2011
View article titled, Retinoic Acid Enhances TRAIL-Induced Apoptosis in Cancer Cells by Upregulating TRAIL Receptor 1 Expression
Open the PDF for Retinoic Acid Enhances TRAIL-Induced Apoptosis in Cancer Cells by Upregulating TRAIL Receptor 1 Expression in another window
Includes: Supplementary data
Journal Articles

Abstract 4782: The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through JNK-dependent downregulation of c-FLIP in head and neck cancer cells

Liqun Zhao, Ping Yue, Sagar Lonial, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4782.
https://doi.org/10.1158/1538-7445.AM2011-4782
Published: 15 April 2011
View article titled, Abstract 4782: The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through JNK-dependent downregulation of c-FLIP in head and neck cancer cells
Journal Articles

Abstract 1953: Elevated eukaryotic translation initiation factor 4E (eIF4E) is involved in erlotinib resistance

Yikun Li, Junghui Koo, Songqing Fan, Ping Yue, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, Shi-Yon Sun
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1953.
https://doi.org/10.1158/1538-7445.AM2011-1953
Published: 15 April 2011
View article titled, Abstract 1953: Elevated eukaryotic translation initiation factor 4E (eIF4E) is involved in erlotinib resistance
Journal Articles

Abstract 2567: Preclinical evaluation of Poly (ADP) Ribose Polymerase (PARP) enzyme inhibitor, ABT-888, in combination with cytotoxic agents in small cell lung cancer (SCLC)

Taofeek K. Owonikoko, Guojing Zhang, Ping Yue, Suresh Ramalingam, Fadlo Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2567.
https://doi.org/10.1158/1538-7445.AM2011-2567
Published: 15 April 2011
View article titled, Abstract 2567: Preclinical evaluation of Poly (ADP) Ribose Polymerase (PARP) enzyme inhibitor, ABT-888, in combination with cytotoxic agents in small cell lung cancer (SCLC)
Journal Articles

Abstract LB-335: Retinoic acid regulates TRAIL-R1 expression through a retinoic acid receptor-dependent mechanism and enhances death receptor-induced apoptosis

Latha Dhandapani, Ping Yue, Suresh S. Ramalingam, Fadlo R. Khuri, Shi Yong Sun
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-335.
https://doi.org/10.1158/1538-7445.AM10-LB-335
Published: 15 April 2010
View article titled, Abstract LB-335: Retinoic acid regulates TRAIL-R1 expression through a retinoic acid receptor-dependent mechanism and enhances death receptor-induced apoptosis
Journal Articles

Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy

Lei Fu, Young-Ae Kim, Xuerong Wang, Xiaoyun Wu, Ping Yue, Sagar Lonial, Fadlo R. Khuri, Shi-Yong Sun
Journal: Cancer Research
Cancer Res (2009) 69 (23): 8967–8976.
https://doi.org/10.1158/0008-5472.CAN-09-2190
Published: 30 November 2009
View article titled, Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy
Open the PDF for Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy in another window
Includes: Supplementary data